Avita Medical, Inc. Common Stock (NASDAQ: RCEL) last traded at $13.21, down 0.90% on the session. The quote above updates while this page is open; the figures below are drawn from Avita Medical, Inc. Common Stock’s own filings and are restated only when a new one is published.
Avita Medical, Inc. Common Stock trades on NASDAQ under the ticker RCEL. Its market capitalisation is $408.54 million.
Valuation measures for Avita Medical, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $408.54M |
|---|---|
| Enterprise value | $475.02M |
| Price / sales | 5.40 |
| Beta | 1.46 |
Trailing-twelve-month figures tagged in Avita Medical, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $75.63M |
| Net income (TTM) | -$43.08M |
|---|
| EPS (TTM) | -$1.43 |
|---|
| Gross margin | 81.56% |
|---|
| Operating margin | -46.56% |
|---|
| Cash | $9.14M |
|---|
Range and volume for RCEL over the past 52 weeks.
| 52-week high | $13.71 |
|---|---|
| 52-week low | $3.22 |
| Volume | 280.5K |
| Average volume | 440.2K |
| Previous close | $13.33 |
Invest a chosen dollar amount in Avita Medical, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RCEL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.